Based on meta-analysis from 34 studies, a significant increased risk of colorectal cancer was observed for those individuals with rapid acetylator polymorphisms in NAT2 (OR 1.07, 95% CI 1.01–1.13). The gene discussed is NAT2; the disease is colorectal cancer.